Loncom Pharmaceutical's Revefenacin API is a novel therapeutic agent for managing chronic obstructive pulmonary disease (COPD). As a long-acting muscarinic antagonist, it is designed for daily maintenance treatment of COPD, underscoring our dedication to advancing respiratory care.
